CGM Sensors and Health Apps: The Future of Continuous Glucose Tracking
Continuous glucose monitoring (CGM) technology has transformed the management of diabetes, and is increasingly being adopted by health-conscious individuals without diabetes to optimise metabolic performance and understand how their bodies respond to food, exercise, and lifestyle factors. A CGM sensor — a small filament inserted just under the skin, typically on the upper arm or abdomen — measures glucose in the interstitial fluid every 5-15 minutes and transmits readings wirelessly to a smartphone. The resulting data stream is far richer than finger-stick testing: it reveals not just where glucose is at a given moment, but where it is heading (trend direction), how fast it is changing (rate of change), and how variable it has been over time (glucose variability). Health apps like the Hype app are designed to integrate this data alongside other health metrics for a comprehensive metabolic picture.
What CGM Reveals That Finger-Stick Testing Cannot
Finger-stick testing provides a single data point — a glucose snapshot at a specific moment. CGM provides a continuous narrative. With CGM data, users can identify: (1) Postprandial glucose response — exactly how high glucose spikes after each meal and how long it takes to return to baseline, revealing which foods cause problematic responses; (2) Nocturnal hypoglycaemia — glucose drops during sleep that users are entirely unaware of and that can cause morning fatigue and cognitive fog; (3) Exercise glycaemic response — whether exercise raises glucose (common in intense anaerobic exercise due to adrenaline-driven hepatic glucose release) or lowers it (common in moderate aerobic exercise via increased glucose uptake); (4) Glucose variability — the amplitude of glucose oscillations that independently predict cardiovascular and diabetes complications.
Interpreting Time in Range: The Key CGM Metric
The most clinically meaningful summary metric from CGM is Time in Range (TIR) — the percentage of time your glucose spends within the target range of 70-180 mg/dL (3.9-10.0 mmol/L). The 2017 International Consensus on CGM recommends a TIR target of 70% or above for most adults with diabetes; for older adults and those at high hypoglycaemia risk, 50% is acceptable. For healthy individuals without diabetes, TIR above 90% is typical and expected. Time below range (glucose below 70 mg/dL) should be minimised — the consensus target is under 4% total and under 1% severe hypoglycaemia (below 54 mg/dL). Time above range (glucose above 180 mg/dL) should ideally be under 25% of the monitoring period.
Connecting CGM to the Hype App Ecosystem
The Hype app supports manual entry of glucose readings and structured CGM data import from connected monitoring devices. When CGM data is loaded into the app, users can view glucose trends alongside: resting heart rate from the Hype Smart Ring (elevated resting HR may accompany glucose dysregulation), sleep quality data (poor sleep quality correlates with higher fasting glucose the following morning), step count and activity level, and blood pressure readings if logged manually. These multi-metric correlations enable users to identify which lifestyle behaviours most powerfully affect their personal glucose patterns — information that a glucose reading in isolation cannot provide.
- Time in Range above 70%: acceptable glycaemic control — optimise further with dietary adjustments and consistent exercise
- Time above Range above 25%: excess postprandial glucose exposure — review meal composition, carbohydrate portions, and meal timing
- Time below Range above 4%: recurrent hypoglycaemia — review medication, meal spacing, and exercise timing with healthcare provider
- Glucose variability coefficient of variation above 36%: high variability — independent cardiovascular risk factor requiring dietary stabilisation
CGM for Metabolic Optimisation in Non-Diabetic Users
An emerging category of CGM users — health-conscious individuals without diabetes — uses continuous glucose data to personalise diet, optimise exercise timing, and reduce postprandial glucose variability as a preventive health strategy. Research indicates that even within the 'normal' fasting glucose range, individuals with repeatedly elevated postprandial responses have higher cardiovascular risk over time. By identifying foods that cause personally problematic glucose spikes — which can differ substantially between individuals even for identical meals — non-diabetic CGM users can make targeted dietary modifications that reduce long-term metabolic risk. The Hype app supports this use case by enabling annotation of glucose data with meal content, exercise, and sleep quality, turning raw numbers into actionable personalised nutrition insights.
References
- American Diabetes Association. 'Standards of Medical Care in Diabetes — 2023.' Diabetes Care. 2023;46(Suppl 1):S1-S291. [Link]
- Danne T, et al. 'International consensus on use of continuous glucose monitoring.' Diabetes Care. 2017;40(12):1631-1640. [Link]
- Colberg SR, et al. 'Physical activity/exercise and diabetes: a position statement of the American Diabetes Association.' Diabetes Care. 2016;39(11):2065-2079. [Link]
- Dunkley AJ, et al. 'Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions.' Diabetes Care. 2014;37(4):922-933. [Link]
- Nathan DM, et al. 'Impaired fasting glucose and impaired glucose tolerance: implications for care.' Diabetes Care. 2007;30(3):753-759. [Link]
- Knowler WC, et al. 'Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.' N Engl J Med. 2002;346(6):393-403. [Link]